“
TL;DR
This systematic review followed PRISMA guidelines to synthesize literature on bioprinting's potential impact on health-related quality of life.
Bioengineering · 7 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This systematic review followed PRISMA guidelines to synthesize literature on bioprinting's potential impact on health-related quality of life.
This systematic review followed PRISMA guidelines to synthesize literature on bioprinting's potential impact on health-related quality of life. After screening 468 initial articles, 128 full-text papers were included for analysis. The review identifies several potential benefits, including personalized part production, saving lives, reducing organ transplant rejection risks, accelerating skin regeneration, and generating homocellular tissue models. However, the authors note that many advancements are still in the research stage. They conclude that while bioprinting shows promise for revolutionizing medicine and improving patient outcomes, extensive clinical trials, long-term assessments, and economic evaluations are needed before widespread clinical adoption.